Literature DB >> 20830541

Countermeasures against physical motion in schoolchildren requiring no sedation during rest and stress myocardial perfusion imaging with technetium-99m-tetrofosmin.

Hajime Monzen1, Yuko Ban, Makoto Hirata, Akira Nakanishi, Takatoshi Suzuki, Tsutomu Inoue, Taku Yamamoto, Makoto Ogasawara, Chika Tanaka, Toru Iwasa, Rumio Yuki.   

Abstract

For children, cardiac nuclear medicine imaging has not been widely used because of problems of physical motion, even in schoolchildren who require no sedation. In this study, rest-stress myocardial perfusion imaging (MPI) with technetium-99m-tetrofosmin (Tc-99m TF) was performed with the use of a Vac-Loc cushion, a patient immobilizer commonly used for radiotherapy, for immobilizing school-age patients. The immobilizer attenuated the gamma radiation by 6%. By visual assessment, physical motion-related artifacts were markedly improved in images acquired with the immobilizer, compared to those without. In the assessment of image reproducibility with the immobilizer, taking the reproducibility as 2.5Σ + 0.7σ, there were deviations of 4.45, 5.28, and 3.28 mm along the X-, Y-, and Z-axes, respectively, demonstrating a high reproducibility and a negligible rest-stress position error. It is suggested that for radiotherapy, the immobilizer could expand the versatility of MPI while allowing only minimal physical motion in children.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830541     DOI: 10.1007/s12194-010-0100-3

Source DB:  PubMed          Journal:  Radiol Phys Technol        ISSN: 1865-0333


  7 in total

1.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy.

Authors:  M van Herk; P Remeijer; C Rasch; J V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

2.  Pediatric nuclear medicine, Part II: Common procedures and considerations.

Authors:  T A Veitch
Journal:  J Nucl Med Technol       Date:  2000-06

3.  [Phase I clinical trial of a new myocardial imaging agent, 99mTc-PPN1011].

Authors:  A Kubo; K Nakamura; J Hashimoto; T Sammiya; S Iwanaga; S Hashimoto; Y Sasaki
Journal:  Kaku Igaku       Date:  1992-10

4.  [Assessment of whole body PET/MRI fusion imaging using automated software: usefulness of partial body fusion].

Authors:  Yoshitada Nakano; Toshiou Fujibuchi; Tomoko Isobe; Yoshitaka Uchida; Toshiki Kazama; Kazuo Hamada; Takashi Kikawa; Hisao Ito
Journal:  Nihon Hoshasen Gijutsu Gakkai Zasshi       Date:  2006-06-20

5.  Exploring a technique for reducing the influence of scattered rays from surrounding organs to the heart during myocardial perfusion scintigraphy with technetium-99m sestamibi and technetium-99m tetrofosmin.

Authors:  Hajime Monzen; Masatake Hara; Makoto Hirata; Akira Nakanishi; Makoto Ogasawara; Takatoshi Suzuki; Tamie Sato; Hisashi Shimoyama; Futoshi Tadehara; Kunihiko Hirose; Rumio Yuki
Journal:  Ann Nucl Med       Date:  2006-12       Impact factor: 2.668

6.  New protocol of myocardial SPECT imaging with technetium-99m sestamibi for reducing the time interval between rest and adenosine stress phases.

Authors:  Hajime Monzen; Masatake Hara; Akira Nakanishi; Makoto Hirata; Takatoshi Suzuki; Makoto Ogasawara; Hirokazu Higuchi; Hisato Kobayashi; Rumio Yuki; Kunihiko Hirose
Journal:  Radiol Phys Technol       Date:  2008-12-12

7.  Feasibility of a rapid protocol of 1-day single-isotope rest/adenosine stress Tc-99m sestamibi ECG-gated myocardial perfusion imaging.

Authors:  Futoshi Tadehara; Hideya Yamamoto; Shuji Tsujiyama; Toshihide Hinoi; Shusuke Matsuo; Naoya Matsumoto; Yuichi Sato; Nobuoki Kohno
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.